Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

Integrated Raman Imaging System

By Drug Discovery Trends Editor | July 20, 2010

veecoVeeco Instruments Inc., the leading provider of atomic force microscopy technology to the nanoscience community, announces the release of the IRIS models for Innova and BioScope Catalyst Atomic Force Microscopes (AFMs) to provide superior integration and accessibility for combined atomic force microscopy and Raman spectroscopy research. The new systems feature proprietary AFM performance and ease-of-use innovations that allow researchers to generate advanced AFM data simply and routinely, regardless of user skill level. The IRIS systems utilize scanning mechanisms and optical access that are tailored precisely to enable co-localized and high spatial resolution spectroscopy in life science or materials research.


“Researchers have relied on custom systems to combine AFM with spectroscopy, and there is a real need for commercial products that allow a greater percentage of spectroscopists to perform these complimentary techniques more easily and accurately,” said Mark R. Munch, Ph.D, Executive Vice President, Veeco Metrology & Instrumentation. “Our extensive AFM expertise and close collaboration with the leading inverted microscope and Raman spectrometer manufacturers have allowed us to develop seamlessly integrated AFM-Raman systems that can be tailored to specific application requirements, allowing researchers to concentrate on the data rather than the nuances of the technologies.”


“ScanAsyst Imaging Mode and other recent Veeco innovations have revolutionized bio-AFM by making it dramatically easier for researchers of all experience levels to perform specialized experiments,” added David Rossi, Vice President and General Manager of Veeco’s AFM Business. “With the Catalyst-IRIS and Innova-IRIS Systems, Veeco has taken the next step, leveraging technological advances to bring the full combined power of co-located AFM and Raman studies to targeted applications, including the characterization of photovoltaic devices, nanostructured materials, and biological samples. The ability to correlate the high quality data from Raman spectroscopy and the unique nanoscale mechanical properties provided by Veeco AFM will enable researchers to push into new frontiers of research.”


Veeco Instruments Inc.


Filed Under: Drug Discovery

 

Related Articles Read More >

If Trump gets Europe to pay more for drugs, more new medicines could follow — eventually
Antibody - visual concept of immune System - 3D illustration
Fresenius picks the biosimilars, WuXi Biologics builds them in a deal covering up to 37 candidates
Physician in a white coat reviewing information on a tablet with a patient in an exam room.
What real-world data shows about current cancer care
Roche Towers, Basel, Switzerland
Roche picks cancer targets, Hansoh builds the ADCs in deal with $400 million upfront
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Drug Delivery Business News
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Pharmaceutical Processing World
  • R&D World
  • Subscribe to our E-Newsletter
  • About Us
  • Contact Us

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Views
    • Webinars
    • PharmSci360
  • Pharma 50
    • 2026 Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE